In addition, 5-BDBD treatment significantly inhibited P2X4R expression in monocytes and microglia after ischemic stroke, while reducing neurological deficit scores, interleukin-1 beta (IL-1β) levels, and BBB permeability (Srivastava et al., 2020). This evidence concerns the gene P2RX4 and ischemic stroke.